Log in to save to my catalogue

Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study

Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4748311

Publication information

Publisher

United States: John Wiley and Sons Inc

More information

Scope and Contents

Contents

Objective
This study prospectively assessed putative promising biomarkers for use in assessing infants with spinal muscular atrophy (SMA).
Methods
This prospective, multi‐center natural history study targeted the enrollment of SMA infants and healthy control infants less than 6 months of age. Recruitment occurred at 14 centers within the N...

Alternative Titles

Full title

Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4748311

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4748311

Other Identifiers

ISSN

2328-9503

E-ISSN

2328-9503

DOI

10.1002/acn3.283

How to access this item